Central effects of diphenylhydantoin (dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration.
D000293:Adolescent; D000328:Adult; D000643:Ammonium Chloride / Q000627:therapeutic use*; D001639:Bicarbonates; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008607:Intellectual Disability / Q000188:drug therapy*; D008064:Lipidoses / Q000188:drug therapy; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use*; D011324:Primidone / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use*
D001639:Bicarbonates; D000643:Ammonium Chloride; D011324:Primidone; D010672:Phenytoin; D012964:Sodium; D010634:Phenobarbital